NASDAQ:CTXR   Citius Pharmaceuticals, Inc.
PENNANT/ DESCENDING TRIANGLE ON CTXR. WITH CATALYST AHEAD OF PHASE 3 DATA FOR CATHETER RELATED BLOOD STREAM INFECTION 2H 2020 CTXR , SHOULD SEE A BREAKOUT FOR A NICE RUN
评论:
ALSO COVID PLAY
免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。